LeonaBio (NASDAQ: LONA) shareholders approve directors, EY auditor and executive pay cadence
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
LeonaBio, Inc. reported the results of its 2026 Annual Meeting of Stockholders. Of 9,393,514 common shares outstanding as of May 1, 2026, 7,908,604 shares were present or represented by proxy, representing approximately 84.19% of shares entitled to vote, which was enough to conduct business.
Stockholders elected three Class III directors—Kelly A. Romano, James A. Johnson and Natalie Holles—to terms running until the 2029 annual meeting, with strong majorities of votes cast in favor. They also ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
In advisory votes, stockholders approved the compensation of LeonaBio’s named executive officers and indicated a preference to hold future advisory votes on executive pay every three years. The company and its board plan to follow a three-year frequency until the next required vote on this question.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares outstanding: 9,393,514 shares
Shares present or by proxy: 7,908,604 shares
Quorum percentage: 84.19%
+4 more
7 metrics
Shares outstanding
9,393,514 shares
Common stock outstanding as of May 1, 2026 (record date)
Shares present or by proxy
7,908,604 shares
Shares represented at 2026 Annual Meeting, about 84.19% of entitled
Quorum percentage
84.19%
Portion of total shares entitled to vote represented at meeting
Auditor ratification votes for
7,824,681 shares
Votes for Ernst & Young LLP as 2026 independent auditor
Auditor ratification votes against
10,708 shares
Votes against Ernst & Young LLP as 2026 auditor
Say-on-pay votes for
5,310,614 shares
Advisory approval of named executive officer compensation
Broker non-votes on proposals 1 & 3
2,555,571 shares
Broker non-votes recorded on director elections and say-on-pay
Key Terms
broker non-votes, independent registered public accounting firm, advisory basis, non-binding advisory vote, +1 more
5 terms
broker non-votes financial
"Nominees of the Board | For | Withhold | Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
advisory basis financial
"approved, on an advisory basis, the compensation of the Company’s named executive officers"
non-binding advisory vote financial
"hold a non-binding advisory vote regarding the compensation of its named executive officers every 3 years"
A non-binding advisory vote is a shareholder vote that expresses investors’ opinion on a proposal (such as executive pay, corporate policy, or governance practices) but does not legally force the company to act. Think of it like a customer survey: it signals whether owners approve or disapprove and can pressure boards and managers to change course, so investors watch the result as an indicator of governance risk and potential future shifts in company strategy or leadership.
Emerging Growth Company regulatory
"Emerging Growth Company |"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
Were LeonaBio’s Class III director nominees elected at the 2026 annual meeting?
Yes. Stockholders elected Kelly A. Romano, James A. Johnson and Natalie Holles as Class III directors. Each received a clear majority of votes cast “for” versus “withheld,” and will serve until the 2029 annual meeting or until a successor is duly elected and qualified.
Did LeonaBio (LONA) stockholders approve the company’s auditor for 2026?
Yes. Stockholders ratified Ernst & Young LLP as LeonaBio’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Voting results were 7,824,681 shares for, 10,708 against and 73,215 abstaining, with no broker non-votes reported on this proposal.
How often will LeonaBio hold advisory say-on-pay votes going forward?
Shareholders indicated a preference for holding advisory votes on executive compensation every three years. Consistent with this result and the board’s recommendation, LeonaBio plans to conduct a non-binding advisory vote on named executive officer pay every three years until the next required frequency vote.